Position history for BlackRock, Inc.'s holdings in SAREPTA THERAPEUTICS
BlackRock, Inc. holds 14.8M shares of SRPT (SAREPTA THERAPEUTICS), worth $321.1M as of 2026-Q1. The position was increased (+3.3% shares). SRPT represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$321.1M
Current Shares
14.8M
Total Value Change
-$1B
Total Shares Change
+3.6M
Other major holders of SRPT: BlackRock Finance, Inc., Capital Research Global Investors, VANGUARD GROUP INC, Capital International Investors
Increased |
| 14.8M |
+3.3% |
| $321.1M |
| 0.0% |
| $15.87 |
32 |
| 2025-Q4 | Increased | 14.3M | +8.2% | $307.4M | 0.0% | $21.49 | 34 |
| 2025-Q3 | Increased | 13.2M | +8.9% | $254.4M | 0.0% | $18.82 | 34 |
| 2025-Q2 | Increased | 12.1M | +22.3% | $207.2M | 0.0% | $17.11 | 37 |
| 2025-Q1 | Decreased | 9.9M | -11.5% | $632.3M | 0.0% | $70.41 | 0 |
| 2024-Q4 | New | 11.2M | - | $1.4B | 0.0% | $121.19 | 44 |